Opko Health, Inc. (OPK): Depreciation & Amortization
$91.63M
Year ended 2025-12-31
$89.72M
Trailing 12 months to 2026-06-30
-5.5%
3-year compound annual growth
+1.4%
5-year compound annual growth
+8.0%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $91.63M | -6.7% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $98.18M | -6.8% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $105.30M | -3.1% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $108.66M | +38.0% | 2025-03-03, From 2022-01-01 |
| 2021-12-31 | $78.72M | -7.8% | 2024-03-01, From 2021-01-01 |
| 2020-12-31 | $85.36M | -9.0% | 2023-02-27, From 2020-01-01 |
| 2019-12-31 | $93.81M | -3.6% | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $97.34M | -4.7% | 2021-02-18, From 2018-01-01 |
| 2017-12-31 | $102.09M | +5.7% | 2020-03-02, From 2017-01-01 |
| 2016-12-31 | $96.58M | +128.6% | 2019-03-01, From 2016-01-01 |
| 2015-12-31 | $42.25M | +183.0% | 2018-03-01, From 2015-01-01 |
| 2014-12-31 | $14.93M | -1.9% | 2017-03-01, From 2014-01-01 |
| 2013-12-31 | $15.22M | +49.8% | 2016-02-29, From 2013-01-01 |
| 2012-12-31 | $10.16M | +165.3% | 2015-02-27, From 2012-01-01 |
| 2011-12-31 | $3.83M | +73.5% | 2014-03-03, From 2011-01-01 |
| 2010-12-31 | $2.21M | +291.3% | 2013-03-18, From 2010-01-01 |
| 2009-12-31 | $564.0K | n/a | 2012-03-15, From 2009-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Opko Health, Inc. (OPK) | 2025-12-31 | $91.63M | -6.7% |
| TG Therapeutics, Inc. (TGTX) | 2025-12-31 | $59.0K | -13.2% |
| Organogenesis Holdings Inc. (ORGO) | 2025-12-31 | $15.27M | +12.1% |
| HUTCHMED (China) Ltd (HCM) | 2025-12-31 | $13.31M | +7.8% |
| Ultragenyx Pharmaceutical Inc. (RARE) | 2025-12-31 | $35.00M | -2.8% |
| Kiniksa Pharmaceuticals International, plc (KNSA) | 2025-12-31 | $1.55M | -8.3% |
| Mirum Pharmaceuticals, Inc. (MIRM) | 2025-12-31 | $24.24M | +2.6% |
| Supernus Pharmaceuticals, Inc. (SUPN) | 2025-12-31 | $91.56M | +13.9% |
| Pacira BioSciences, Inc. (PCRX) | 2025-12-31 | $91.02M | +15.5% |
Compare OPK, TGTX, ORGO, HCM side by side · Screen every company in Pharmaceutical Preparations ↗